AbbVie

ABBV · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.689%

12M weight contribution

-0.096 pp

3M weight contribution

-0.025 pp

12M price return

+15.5%

Share of matched S&P 500 members

Monthly observations through Nov 2021

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Nov 2021	$203.8bn	0.689%	-0.096 pp	+15.5%	No
Oct 2021	$202.6bn	0.677%	-0.034 pp	+41.2%	No
Sep 2021	$190.6bn	0.669%	+0.669 pp	+29.3%	No
Aug 2021	$213.4bn	0.714%	+0.713 pp	+32.4%	Yes
Jul 2021	$205.4bn	0.704%	+0.704 pp	+28.6%	Yes
Jun 2021	$198.9bn	0.702%	+0.702 pp	+20.5%	Yes
May 2021	$199.9bn	0.716%	+0.715 pp	+28.3%	Yes
Apr 2021	$196.9bn	0.714%	+0.033 pp	+42.5%	Yes
Mar 2021	$191.1bn	0.374%	+0.373 pp	+49.6%	No
Feb 2021	$190.3bn	0.380%	+0.380 pp	+32.4%	No
Jan 2021	$180.9bn	0.433%	-0.158 pp	+33.3%	No
Dec 2020	$189.2bn	0.766%	+0.123 pp	+27.7%	Yes
Nov 2020	$184.6bn	0.784%	+0.131 pp	+25.8%	Yes
Oct 2020	$150.2bn	0.711%	+0.098 pp	+12.9%	Yes
Sep 2020	$154.6bn	0.001%	-0.594 pp	+22.2%	No
Aug 2020	$169.0bn	0.001%	-0.528 pp	+53.9%	No
Jul 2020	$140.2bn	0.001%	-0.523 pp	+50.5%	No
Jun 2020	$145.0bn	0.001%	-0.579 pp	+43.0%	No
May 2020	$136.8bn	0.001%	-0.660 pp	+28.0%	No
Apr 2020	$121.6bn	0.680%	+0.028 pp	+9.7%	Yes
Mar 2020	$112.7bn	0.001%	-0.682 pp	+0.0%	No
Feb 2020	$126.8bn	0.001%	-0.677 pp	+14.4%	No
Jan 2020	$119.8bn	0.591%	+0.193 pp	+6.7%	No
Dec 2019	$130.9bn	0.642%	+0.147 pp	+1.5%	Yes

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.